-
Study aim
-
Determining the effect of prednisolone in bronchoscopic procedure in the treatment of patients with tracheal stenosis referred to Shahid Beheshti Hospital in 1401
-
Design
-
A clinical trial with a control group, with parallel groups, 1 blind, randomized, phase 0 on 40 patients. It will be generated from R software for randomization
-
Settings and conduct
-
Two control groups (n=20), patients who undergo bronchoscopy, undergo repeated bronchoscopy 3 weeks later (21 days) without receiving any medication (placebo), and the second group of patients after the first stage bronchoscopy, for 3 weeks. They receive 0.5 mg/kg prednisolone daily and after 21 days, they undergo bronchoscopy again.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
1) Patients suffering from tracheal stenosis.
2) Patients who have a stenosis equal to less than 1.5 cm.
3) Patients who are candidates for rigid bronchoscopy.
Exit criteria:
1) Patients who are candidates for bronchoscopy due to other diseases (except for tracheal stenosis).
2) Patients whose stenosis length is more than 1.5 cm.
3) Patients suffering from underlying diseases for whom corticosteroid administration is contraindicated.
-
Intervention groups
-
In this study, the statistical sample is divided into two groups (n=20), so that in the control group, patients who undergo bronchoscopy, 3 weeks later (21 days) without receiving any medicine (receive placebo), undergo bronchoscopy again. And in the second group of patients, after the first stage bronchoscopy, they receive 0.5 mg/kg prednisolone (26) daily for 3 weeks and after 21 days, they undergo bronchoscopy again.
-
Main outcome variables
-
Treating patients with tracheal stenosis and preventing or minimizing complications caused by bronchoscopy and improving the course of treatment of patients with tracheal stenosis